Cargando…

537. Implementation of a Workflow for COVID-19 Monoclonal Antibody Infusions at a Veterans Affairs Medical Center

BACKGROUND: In the setting of the global pandemic due to COVID-19, high-risk patients with mild to moderate disease were identified as a group who would benefit from COVID-19 monoclonal antibody (mAB) treatment to mitigate progression to severe disease or hospitalization. The U.S. Food and Drug Admi...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Pratish C, Adenew, Ayne, McKnight, Angela, Jeng, Kevin, Liappis, Angelike P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644918/
http://dx.doi.org/10.1093/ofid/ofab466.736

Ejemplares similares